NewEdge Advisors’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-100
Closed -$1.12K 3848
2024
Q2
$1.12K Buy
+100
New +$1.16K ﹤0.01% 3443
2023
Q4
Sell
-500
Closed -$7.38K 3776
2023
Q3
$7.38K Sell
500
-500
-50% -$7.03K ﹤0.01% 2682
2023
Q2
$12.9K Sell
1,000
-143
-13% -$1.63K ﹤0.01% 2528
2023
Q1
$11.2K Sell
1,143
-500
-30% -$5.34K ﹤0.01% 2529
2022
Q4
$17 Buy
+1,643
New +$19.1K ﹤0.01% 3624

Other funds holding DVAX

NewEdge Advisors's DVAX Position: Q3 2024 in Review

NewEdge Advisors sold out of Dynavax Technologies (DVAX) in Q3 2024, closing a stake of 100 shares — an estimated $1.12K sold.

NewEdge Advisors first reported a position in DVAX in Q4 2022 and held it in 5 quarters. The position peaked at $12.9K in Q2 2023. 251 funds tracked by Wall St. Rank hold DVAX as of Q3 2024.

  • NewEdge Advisors reported no remaining Dynavax Technologies position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 100 Dynavax Technologies shares in Q3 2024, an estimated $1.12K.
  • NewEdge Advisors first reported a position in Dynavax Technologies in Q4 2022 and held it in 5 quarters.
  • NewEdge Advisors's Dynavax Technologies position peaked at $12.9K in Q2 2023.
  • 251 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.